Get the Stockscreener App
0.83
3.38%
-0.029
After Hours:
.83
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Clinical Trials News Live Feed - StockTitan
ADILAdial Pharmaceuticals, Inc Latest Stock News & Market Updates - StockTitan
Adial completes key study for alcohol disorder drug - Investing.com
Game-Changing Alcohol Addiction Treatment Clears Critical FDA Hurdle - StockTitan
EXCLUSIVE: Adial Pharmaceuticals Reveals Positive Pharmacokinetics Study Results Of AD04 For Alcohol Use Disorder - Benzinga
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 60.8% in January - Defense World
Adial Pharma stock hits 52-week low at $0.72 amid market challenges - Investing.com Nigeria
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today - MSN
Adial Pharmaceuticals to Commence Business Development Meetings - Defense World
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Update - Defense World
Adial Pharmaceuticals Focuses on Strategic Growth Initiatives - TipRanks
Adial Pharmaceuticals Highlights AD04 for Alcohol Use Disorder - TipRanks
Alcohol Use Disorder Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Epidemiology, Therapies, Treatment, Companies by DelveInsight - Barchart
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Up 16.4% in December - Defense World
Adial Pharmaceuticals (NASDAQ:ADIL) Stock Quotes, Forecast and News Summary - Benzinga
Adial Pharmaceuticals’ New Purchase Agreement with Alumni Capital - TipRanks
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Drops By 71.7% - Defense World
Alcohol Use Disorder Market Set for Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Adial Pharmaceuticals revises CEO's compensation package By Investing.com - Investing.com South Africa
Adial Pharmaceuticals revises CEO's compensation package - Investing.com India
Adial Pharmaceuticals secures new patent for AUD therapy By Investing.com - Investing.com South Africa
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations - AOL
Adial Pharmaceuticals, Inc. Updates on Onward Phase 3 Pivotal Trial - Marketscreener.com
Adial Pharmaceuticals secures new patent for AUD therapy - Investing.com
Adial Pharmaceuticals Granted Key U.S. Patent for the - GlobeNewswire
Adial Pharmaceuticals Secures Key Patent for Alcohol Use Disorder Treatment Technology - StockTitan
Alcohol Use Disorder Treatment Market Report Analysis - openPR
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Sees Large Growth in Short Interest - Defense World
Adial Pharmaceuticals (ADIL) Upgraded to Buy: Here's What You Should Know - MSN
Equities Analysts Offer Predictions for ADIL FY2024 Earnings - Defense World
Adial Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adial Pharmaceuticals (NASDAQ:ADIL) Coverage Initiated at Rodman & Renshaw - Defense World
RODMAN&RENSHAW Upgrades Adial Pharmaceuticals (NASDAQ:ADIL) to “Strong-Buy” - Defense World
ARMISTICE CAPITAL, LLC Acquires New Stake in Adial Pharmaceutica - GuruFocus.com
Rodman & Renshaw sets stock target, buy rating on Adial Pharma, cites potential - Investing.com India
U.S. STOCKS Oklo, Adial Pharma, Sonos - XM
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder - AOL
Adial Pharmaceuticals completes key study for FDA meeting - Investing.com
Adial Pharmaceuticals Announces Positive Topline Results - GlobeNewswire
Adial Pharma's AD04 Drug Hits Key Milestones in Alcohol Use Disorder Treatment Study | ADIL Stock News - StockTitan
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
Adial Pharma Reports Mixed Q3: AUD Drug Study Advances Despite Widening Losses | ADIL Stock News - StockTitan
Adial Pharmaceuticals Approves Strategic Changes at Annual Meeting - TipRanks
Adial Pharmaceuticals Appoints Vinay Shah as CFO - Defense World
Adial Pharmaceuticals names new CFO amid strategic growth By Investing.com - Investing.com Australia
Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer - GlobeNewswire
Adial Pharmaceuticals names new CFO amid strategic growth - Investing.com
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):